Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05284201 · ClinicalTrials.gov registry record · NA
LIFT Home Study of Non-Invasive ARC Therapy for Spinal Cord Injury
A NA study, sponsored by ONWARD Medical.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT05284201: Completed NA study, sponsored by ONWARD Medical.
NCT05284201 is a NA study that has completed, run by ONWARD Medical. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05284201, a NA study, has completed, sponsored by ONWARD Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The LIFT Home Study is an observational, single-arm study designed to assess the safety of non-invasive electrical spinal stimulation (ARC Therapy) administered by the LIFT System to treat upper extremity functional deficits in people with chronic tetraplegia.
Primary Outcome
Observational data regarding the incidence of all adverse events related to the use of the study device and treatment procedures will be reported.
Interventions
- DEVICE LIFT System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2022-03-03 |
| Est. Completion | 2022-09-13 |
| Phase | NA |
What the finished NCT05284201 record still lists
NCT05284201 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which LIFT System is the first listed.
NCT05284201 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05284201 about?
NCT05284201 is a clinical study titled "LIFT Home Study of Non-Invasive ARC Therapy for Spinal Cord Injury". The LIFT Home Study is an observational, single-arm study designed to assess the safety of non-invasive electrical spinal stimulation (ARC Therapy) administered by the LIFT System to treat upper extremity functional deficits in people with chronic tetraplegia.
What is the current status of trial NCT05284201?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2022-03-03. Estimated completion is 2022-09-13.
What interventions are being tested in trial NCT05284201?
The interventions under investigation include: LIFT System (DEVICE).
Who is sponsoring clinical trial NCT05284201?
This trial is sponsored by ONWARD Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05284201's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI